Ren Chao, Zhang Hui, Wu Tian-Tian, Yao Yong-Ming
Trauma Research Center, First Hospital Affiliated to the Chinese PLA General Hospital, Beijing, China.
School of Medicine, Nankai University, Tianjin, China.
Front Immunol. 2017 Dec 18;8:1832. doi: 10.3389/fimmu.2017.01832. eCollection 2017.
Sepsis remains the leading cause of mortality in intensive care units and an intractable condition due to uncontrolled inflammation together with immune suppression. Dysfunction of immune cells is considered as a major cause for poor outcome of septic patients but with little specific treatments. Currently, autophagy that is recognized as an important self-protective mechanism for cellular survival exhibits great potential for maintaining immune homeostasis and alleviating multiple organ failure, which further improves survival of septic animals. The protective effect of autophagy on immune cells covers both innate and adaptive immune responses and refers to various cellular receptors and intracellular signaling. Multiple drugs and measures are reportedly beneficial for septic challenge by inducing autophagy process. Therefore, autophagy might be an effective target for reversing immunosuppression compromised by sepsis.
脓毒症仍然是重症监护病房中导致死亡的主要原因,并且由于炎症失控和免疫抑制而成为一种难以治疗的病症。免疫细胞功能障碍被认为是脓毒症患者预后不良的主要原因,但针对此的特异性治疗方法却很少。目前,自噬被认为是细胞存活的一种重要自我保护机制,在维持免疫稳态和减轻多器官衰竭方面具有巨大潜力,这进一步提高了脓毒症动物的存活率。自噬对免疫细胞的保护作用涵盖先天性和适应性免疫反应,并涉及多种细胞受体和细胞内信号传导。据报道,多种药物和措施通过诱导自噬过程对脓毒症挑战有益。因此,自噬可能是逆转脓毒症所致免疫抑制的有效靶点。